Viking Therapeutics
Trade Viking Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About VKTX
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A.
VKTX Key Statistics
Stock Snapshot
With a market cap of 3.56B, Viking Therapeutics(VKTX) trades at $30.74. The stock has a price-to-earnings ratio of -7.52.
During the trading session on 2026-05-01, Viking Therapeutics(VKTX) shares reached a daily high of $32.00 and a low of $30.30. At a current price of $30.74, the stock is +1.5% higher than the low and still -3.9% under the high.
Trading activity shows a volume of 720.7K, compared to an average daily volume of 2.67M.
Over the past 52 weeks, Viking Therapeutics(VKTX) stock has traded between a high of $43.15 and a low of $22.96.
Over the past 52 weeks, Viking Therapeutics(VKTX) stock has traded between a high of $43.15 and a low of $22.96.
VKTX News
Viking Therapeutics has reported Q1 2026 results, with a net loss of US$158.33 million and basic and diluted loss per share of US$1.37, while also completing pa...
Cash, cash equivalents and short-term investments at quarter end were $603M vs. $706M at previous quarter end. “We are excited to report that the advances and s...
Analyst ratings
89%
of 19 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.